Read + Share
Shah M, Wedam S, Cheng J, Fiero MH, et al. FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or
Metastatic HER2-Positive Breast Cancer. Clin Cancer Res 2020 Oct 14. pii: 1078-0432.CCR-20-2701.
PMID: 33055172
|
 |
|
Shah M, Wedam S, Cheng J, Fiero MH, et al. FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or
Metastatic HER2-Positive Breast Cancer. Clin Cancer Res 2020 Oct 14. pii: 1078-0432.CCR-20-2701.
PMID: 33055172
|
|
|
|